Compound Detail
CHEMBL63
ROLIPRAM 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL63 |
| Name | ROLIPRAM |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | HJORMJIFDVBMOB-UHFFFAOYSA-N |
23
Targets
331
Activities
4
Assay Types
0
PK Parameters
20
Publications
7
Known Names
5
Indications
1
Mechanisms
Molecular Properties
275.4
MW (Da)
2.62
ALogP
3
HBA
1
HBD
47.6
PSA (Ų)
0.92
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Phosphodiesterase 4 inhibitor | INHIBITOR | Phosphodiesterase 4 | ✓ | ✓ |
Indications
Multiple Sclerosis Depressive Disorder Depressive Disorder, Major Huntington Disease Nervous System Diseases
Activity Summary
IC50 285 meas. best 9.51
Ki 30 meas. best 8.8
EC50 15 meas. best 7.58
Kd 1 meas. best 8.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Phosphodiesterase 4 CHEMBL2094267 | IC50 | 9.51 | 7.685 | 0.3 | 18 |
| Phosphodiesterase 4 CHEMBL2093863 | Ki | 8.8 | 7.8142 | 1.6 | 12 |
| Unchecked CHEMBL612545 | Ki | 8.68 | 7.95 | 2.1 | 2 |
| Unchecked CHEMBL612545 | IC50 | 8.6 | 6.3312 | 2.5 | 26 |
| Phosphodiesterase 4 CHEMBL2111373 | IC50 | 8.4 | 8.4 | 4.0 | 3 |
| 3',5'-cyclic-AMP phosphodiesterase 4A CHEMBL254 | IC50 | 8.4 | 6.9217 | 4.0 | 12 |
| 3',5'-cyclic-AMP phosphodiesterase 4B CHEMBL275 | Ki | 8.3 | 6.82 | 5.0 | 5 |
| Phosphodiesterase 4 CHEMBL2093863 | Kd | 8.0 | 8.0 | 10.0 | 1 |
| Phosphodiesterase 4 CHEMBL2094267 | Ki | 7.96 | 7.96 | 11.0 | 1 |
| Phosphodiesterase 4 CHEMBL2093863 | IC50 | 7.7 | 6.213 | 20.0 | 47 |
| 3',5'-cyclic-AMP phosphodiesterase 4B CHEMBL275 | IC50 | 7.7 | 6.2846 | 20.0 | 52 |
| Trachea CHEMBL4296541 | EC50 | 7.58 | 7.3575 | 26.3 | 4 |
| 3',5'-cyclic-AMP phosphodiesterase 4D CHEMBL288 | IC50 | 7.5 | 6.3786 | 31.6 | 69 |
| Homo sapiens CHEMBL372 | IC50 | 7.42 | 6.4414 | 37.9 | 7 |
| Rattus norvegicus CHEMBL376 | IC50 | 7.4 | 7.0 | 40.0 | 2 |
| Zika virus CHEMBL4296612 | IC50 | 7.35 | 7.35 | 44.6 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4D CHEMBL288 | Ki | 7.23 | 6.2871 | 58.9 | 7 |
| PBMC CHEMBL613107 | IC50 | 7.22 | 6.2429 | 60.0 | 14 |
| 3',5'-cyclic-AMP phosphodiesterase 4C CHEMBL291 | IC50 | 6.93 | 5.63 | 118.0 | 9 |
| PBMC CHEMBL613107 | EC50 | 6.89 | 6.89 | 130.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 6.88 | 6.675 | 131.5 | 2 |
| 3',5'-cyclic-AMP phosphodiesterase 4B CHEMBL275 | EC50 | 6.8 | 6.73 | 160.0 | 2 |
| Cavia porcellus CHEMBL369 | IC50 | 6.8 | 6.635 | 160.0 | 2 |
| RAW264.7 CHEMBL612557 | IC50 | 6.72 | 6.72 | 190.0 | 1 |
| Tumor necrosis factor CHEMBL1825 | IC50 | 6.7 | 6.055 | 200.0 | 4 |
| ADMET CHEMBL612558 | IC50 | 6.51 | 6.4367 | 310.0 | 3 |
| ADMET CHEMBL612558 | EC50 | 6.5 | 6.5 | 320.0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4A CHEMBL254 | EC50 | 6.3 | 5.94 | 500.0 | 2 |
| 3',5'-cyclic-AMP phosphodiesterase 4D CHEMBL288 | EC50 | 6.17 | 6.065 | 670.0 | 2 |
| cGMP-specific 3',5'-cyclic phosphodiesterase CHEMBL1827 | IC50 | 6.14 | 6.14 | 720.0 | 1 |
| U-937 CHEMBL612794 | IC50 | 5.95 | 5.93 | 1120.0 | 3 |
| U-937 CHEMBL612794 | EC50 | 5.91 | 5.91 | 1230.0 | 1 |
| Blood CHEMBL613416 | IC50 | 5.83 | 5.83 | 1476.0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4B CHEMBL3382 | IC50 | 5.57 | 5.57 | 2700.0 | 1 |
| Phosphodiesterase 4A CHEMBL3333 | IC50 | 5.44 | 5.44 | 3630.0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase 4A CHEMBL254 | Ki | 5.1 | 5.1 | 7940.0 | 1 |
| Phosphodiesterase, PDE1/PDE5 CHEMBL2097161 | IC50 | 4.02 | 4.02 | 94900.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine